Efficacy of Three Antiemetics in Preventing Nausea & Vomiting

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05016180` - Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery	Phase 2
Withdrawn	`NCT00891761` - A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy	Phase 3
Terminated	`NCT00903396` - Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer	Phase 2
Recruiting	`NCT01696734` - Domperidone in Treating Patients With Gastrointestinal Disorders	Phase 3
Completed	`NCT00293384` - Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant	N/A
Completed	`NCT00006348` - Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment	Phase 3
Completed	`NCT00004895` - Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	Phase 2
Completed	`NCT00003817` - Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy	Phase 2
Active, not recruiting	`NCT06045364` - Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation	Phase 1/Phase 2
Completed	`NCT00978185` - Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy	Phase 3
Completed	`NCT00064272` - UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer	Phase 2
Completed	`NCT00003213` - Drugs to Reduce the Side Effects of Chemotherapy	Phase 3
Recruiting	`NCT05690802` - The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV	N/A
Recruiting	`NCT06314906` - Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer	Phase 3
Completed	`NCT00590317` - Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department	Phase 2
Completed	`NCT03185156` - The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate	Phase 4
Not yet recruiting	`NCT06382012` - Antiemetic Fosaprepitant To Remedy Nausea and Vomiting	Phase 2/Phase 3
Completed	`NCT01590147` - Supportive Intervention Programs Study	N/A
Terminated	`NCT01275664` - Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer	N/A
Completed	`NCT00381862` - Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting	Phase 2

NCT number	NCT05533281
Study type	Interventional
Source	The Second Affiliated Hospital of Chongqing Medical University
Contact
Status	Completed
Phase	Phase 4
Start date	September 15, 2022
Completion date	November 3, 2023

Efficacy of Three Antiemetics in Preventing Nausea and Vomiting

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms